A Randomized, Double-Blind, Active Controlled Clinical Trial of Switching to Vilazodone for Antidepressant-Associated Sexual Dysfunction

Trial Profile

A Randomized, Double-Blind, Active Controlled Clinical Trial of Switching to Vilazodone for Antidepressant-Associated Sexual Dysfunction

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs Vilazodone (Primary) ; Sertraline
  • Indications Major depressive disorder; Sexual function disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Aug 2016 Status changed from recruiting to discontinued.
    • 04 Feb 2016 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018, as reported by ClinicalTrials.gov record.
    • 04 Feb 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top